Congenital Heart Disease (CHD) Global Market Report 2025

Description

Congenital heart disease (CHD) encompasses a spectrum of birth defects affecting the structure and function of the heart present at birth. These defects may involve abnormalities in the heart walls, valves, arteries, and veins near the heart. Treatment for CHD varies depending on the type and severity of the defect and may include medications, catheter-based interventions, open-heart surgery, or heart transplantation.

The primary types of congenital heart disease (CHD) include heart valve defects, heart wall defects, blood vessel defects, and others. Heart valve defects entail abnormalities or malfunctions in the heart valves, which regulate blood flow within the heart. Diagnosis methods may include electrocardiograms, chest X-rays, echocardiograms, transesophageal echocardiograms, pulse oximetry, exercise stress tests, cardiac computed tomography (CT) scans, magnetic resonance imaging (MRI), cardiac catheterization, among others. Treatment options range from interventional cardiology procedures to cardiac surgery, medication management, telemedicine, and lifestyle modifications. CHD affects individuals across all age groups, including infants, children, adolescents, and adults, who receive treatment in hospitals, clinics, diagnostic centers, ambulatory surgical centers, and research and academic institutions.

The congenital heart disease market research report is one of a series of new reports from The Business Research Company that provides congenital heart disease market statistics, including congenital heart disease industry global market size, regional shares, competitors with a congenital heart disease market share, detailed congenital heart disease market segments, market trends and opportunities, and any further data you may need to thrive in the congenital heart disease industry. This congenital heart disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congenital heart disease (CHD) market size has grown rapidly in recent years. It will grow from $4.42 billion in 2024 to $4.87 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to the increased prevalence of risk factors such as obesity and smoking, improved diagnostic technologies, expanded geriatric population, heightened awareness campaigns, enhanced reimbursement policies, and increased investment in research and development.

The congenital heart disease (CHD) market size is expected to see strong growth in the next few years. It will grow to $7.05 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to expanding access to healthcare services in developing regions, continuous innovation in cardiac imaging technologies, growing awareness campaigns promoting early detection and treatment, rising healthcare expenditure globally, and the development of personalized medicine. Major trends in the forecast period include adoption of minimally invasive surgical techniques, expanding use of telemedicine for remote patient monitoring and consultations, rising demand for personalized treatment approaches, development of innovative implantable devices with enhanced functionality and longevity, integration of artificial intelligence and machine learning in diagnostic and therapeutic processes.

The growing prevalence of maternal diabetes is expected to drive the expansion of the congenital heart disease (CHD) market in the future. Maternal diabetes, also known as gestational diabetes mellitus (GDM), develops during pregnancy in women who did not have diabetes before conceiving. It is primarily caused by lifestyle changes, such as sedentary behavior, poor dietary habits, and rising obesity rates among women of childbearing age. Maternal diabetes can increase the risk of congenital heart disease (CHD) in infants, as elevated blood sugar levels in the mother can disrupt fetal heart development. The high glucose levels affect the normal formation of the baby's heart, leading to a higher likelihood of CHD. For example, in October 2023, the National Health Service, a UK government agency, reported that adverse pregnancy outcomes for women diagnosed with type 2 diabetes increased from 4.9% in 2021 to 6.6% in 2022. As a result, the rising number of maternal diabetes cases is contributing to the growth of the congenital heart disease (CHD) market.

Key players in the congenital heart disease market are innovating non-surgical heart valves to enhance patient outcomes and quality of life. Non-surgical heart valves, also known as transcatheters, are medical devices treating heart valve diseases without conventional open-heart surgery. For instance, in February 2023, Medtronic, a US-based medical technology company, reintroduced its Harmony Transcatheter Pulmonary Valve (TPV) System. This system, a minimally invasive alternative to open-heart surgery, addresses patients with congenital heart disease, particularly those with native or surgically repaired right ventricular outflow tract (RVOT) anomalies. It stands as the first FDA-approved valve designed for the right side, offering a non-surgical solution for severe pulmonary valve regurgitation patients. The Harmony TPV System received U.S. FDA approval in 2021 and was reintroduced following a voluntary recall, underscoring Medtronic's dedication to advancing solutions for congenital heart disease patients.

In May 2024, Novartis Healthcare Private Limited, a Switzerland-based pharmaceutical company, partnered with Ayala Healthcare Holdings, Inc. (AC Health) to launch an Integrated Cardiovascular and Cancer Care initiative. This collaboration aims to expand access to innovative treatments for breast cancer, heart failure, and high cholesterol. Ayala Healthcare Holdings, Inc. (AC Health) is a Philippines-based pharmaceutical company specializing in generic drugs.

Major companies operating in the congenital heart disease (CHD) market are Pfizer Inc., AstraZeneca Plc, Abbott Laboratories, Novartis AG, Medtronic, Siemens Healthineers, Philips Healthcare, Roche Diagnostics International Ltd., Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Neusoft Corp., Carestream Health, Midmark Corporation, Contec Medical Systems, Randox Laboratories Ltd., Schiller AG, BPL Medical Technologies, Compumedics Limited, Biocare Medical, Bionet America Inc., Nasan Medical Electronics Pvt Ltd

North America was the largest region in the congenital heart disease (CHD) market in 2024. The regions covered in the congenital heart disease (CHD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the congenital heart disease (CHD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The congenital heart disease (CHD) market consists of revenues earned by entities by providing services such as medical consultations, diagnostic tests, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The congenital heart disease (CHD) market also includes sales of cardiac implants such as pacemakers, implantable cardioverter-defibrillators (ICDs), and ventricular assist devices (VADs). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congenital Heart Disease (CHD) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on congenital heart disease (chd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for congenital heart disease (chd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The congenital heart disease (chd) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Heart Valve Defects; Heart Wall Defects; Blood Vessel Defects; Other Types
2) By Diagnosis: Electrocardiogram; Chest X-ray; Echocardiogram; Transesophageal Echocardiogram; Pulse Oximetry; Exercise Stress Test; Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI); Cardiac Catheterization; Other Diagnosis
3) By Treatment: Interventional Cardiology; Cardiac Surgery; Telemedicine; Medication Management; Lifestyle Modifications
4) By Age Group: Infants; Children; Adolescents; Adults
5) By Application: Hospitals And Clinics; Diagnostic Centers; Ambulatory Surgical Centers; Research And Academic Institutions
Subsegments:
1) By Heart Valve Defects: Aortic Valve Stenosis; Pulmonary Valve Stenosis; Mitral Valve Prolapse; Tricuspid Valve Defects; Valve Regurgitation
2) By Heart Wall Defects: Atrial Septal Defect (ASD); Ventricular Septal Defect (VSD); Atrioventricular Septal Defect (AVSD); Hypoplastic Left Heart Syndrome (HLHS); Tetralogy of Fallot (TOF)
3) By Blood Vessel Defects: Coarctation Of The Aorta; Patent Ductus Arteriosus (PDA); Pulmonary Artery Stenosis; Transposition Of The Great Arteries (TGA); Truncus Arteriosus
4) By Other Types: Single Ventricle Defects; Ebstein's Anomaly; Total Anomalous Pulmonary Venous Return (TAPVR); Coronary Artery Anomalies; Pulmonary Venous Obstruction
Companies Mentioned: Pfizer Inc.; AstraZeneca Plc; Abbott Laboratories; Novartis AG; Medtronic
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r29863

1. Executive Summary

2. Congenital Heart Disease (CHD) Market Characteristics

3. Congenital Heart Disease (CHD) Market Trends And Strategies

4. Congenital Heart Disease (CHD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Congenital Heart Disease (CHD) Growth Analysis And Strategic Analysis Framework

5.1. Global Congenital Heart Disease (CHD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Congenital Heart Disease (CHD) Market Growth Rate Analysis
5.4. Global Congenital Heart Disease (CHD) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Congenital Heart Disease (CHD) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Congenital Heart Disease (CHD) Total Addressable Market (TAM)

6. Congenital Heart Disease (CHD) Market Segmentation

6.1. Global Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Heart Valve Defects
Heart Wall Defects
Blood Vessel Defects
Other Types
6.2. Global Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electrocardiogram
Chest X-ray
Echocardiogram
Transesophageal Echocardiogram
Pulse Oximetry
Exercise Stress Test
Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI)
Cardiac Catheterization
Other Diagnosis
6.3. Global Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Interventional Cardiology
Cardiac Surgery
Telemedicine
Medication Management
Lifestyle Modifications
6.4. Global Congenital Heart Disease (CHD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infants
Children
Adolescents
Adults
6.5. Global Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Centers
Ambulatory Surgical Centers
Research And Academic Institutions
6.6. Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Valve Defects, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Aortic Valve Stenosis
Pulmonary Valve Stenosis
Mitral Valve Prolapse
Tricuspid Valve Defects
Valve Regurgitation
6.7. Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Wall Defects, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atrial Septal Defect (ASD)
Ventricular Septal Defect (VSD)
Atrioventricular Septal Defect (AVSD)
Hypoplastic Left Heart Syndrome (HLHS)
Tetralogy of Fallot (TOF)
6.8. Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Blood Vessel Defects, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Coarctation Of The Aorta
Patent Ductus Arteriosus (PDA)
Pulmonary Artery Stenosis
Transposition Of The Great Arteries (TGA)
Truncus Arteriosus
6.9. Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Ventricle Defects
Ebstein's Anomaly
Total Anomalous Pulmonary Venous Return (TAPVR)
Coronary Artery Anomalies
Pulmonary Venous Obstruction

7. Congenital Heart Disease (CHD) Market Regional And Country Analysis

7.1. Global Congenital Heart Disease (CHD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Congenital Heart Disease (CHD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Congenital Heart Disease (CHD) Market

8.1. Asia-Pacific Congenital Heart Disease (CHD) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Congenital Heart Disease (CHD) Market

9.1. China Congenital Heart Disease (CHD) Market Overview
9.2. China Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Congenital Heart Disease (CHD) Market

10.1. India Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Congenital Heart Disease (CHD) Market

11.1. Japan Congenital Heart Disease (CHD) Market Overview
11.2. Japan Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Congenital Heart Disease (CHD) Market

12.1. Australia Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Congenital Heart Disease (CHD) Market

13.1. Indonesia Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Congenital Heart Disease (CHD) Market

14.1. South Korea Congenital Heart Disease (CHD) Market Overview
14.2. South Korea Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Congenital Heart Disease (CHD) Market

15.1. Western Europe Congenital Heart Disease (CHD) Market Overview
15.2. Western Europe Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Congenital Heart Disease (CHD) Market

16.1. UK Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Congenital Heart Disease (CHD) Market

17.1. Germany Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Congenital Heart Disease (CHD) Market

18.1. France Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Congenital Heart Disease (CHD) Market

19.1. Italy Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Congenital Heart Disease (CHD) Market

20.1. Spain Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Congenital Heart Disease (CHD) Market

21.1. Eastern Europe Congenital Heart Disease (CHD) Market Overview
21.2. Eastern Europe Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Congenital Heart Disease (CHD) Market

22.1. Russia Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Congenital Heart Disease (CHD) Market

23.1. North America Congenital Heart Disease (CHD) Market Overview
23.2. North America Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Congenital Heart Disease (CHD) Market

24.1. USA Congenital Heart Disease (CHD) Market Overview
24.2. USA Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Congenital Heart Disease (CHD) Market

25.1. Canada Congenital Heart Disease (CHD) Market Overview
25.2. Canada Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Congenital Heart Disease (CHD) Market

26.1. South America Congenital Heart Disease (CHD) Market Overview
26.2. South America Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Congenital Heart Disease (CHD) Market

27.1. Brazil Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Congenital Heart Disease (CHD) Market

28.1. Middle East Congenital Heart Disease (CHD) Market Overview
28.2. Middle East Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Congenital Heart Disease (CHD) Market

29.1. Africa Congenital Heart Disease (CHD) Market Overview
29.2. Africa Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Congenital Heart Disease (CHD) Market Competitive Landscape And Company Profiles

30.1. Congenital Heart Disease (CHD) Market Competitive Landscape
30.2. Congenital Heart Disease (CHD) Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Medtronic Overview, Products and Services, Strategy and Financial Analysis

31. Congenital Heart Disease (CHD) Market Other Major And Innovative Companies

31.1. Siemens Healthineers
31.2. Philips Healthcare
31.3. Roche Diagnostics International Ltd.
31.4. Boston Scientific Corp.
31.5. Laboratory Corporation of America Holdings (LabCorp)
31.6. Terumo Corporation
31.7. Mindray Medical International Limited
31.8. Canon Medical Systems Corporation
31.9. Masimo Corporation
31.10. Neusoft Corp.
31.11. Carestream Health
31.12. Midmark Corporation
31.13. Contec Medical Systems
31.14. Randox Laboratories Ltd.
31.15. Schiller AG

32. Global Congenital Heart Disease (CHD) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Congenital Heart Disease (CHD) Market

34. Recent Developments In The Congenital Heart Disease (CHD) Market

35. Congenital Heart Disease (CHD) Market High Potential Countries, Segments and Strategies

35.1 Congenital Heart Disease (CHD) Market In 2029 - Countries Offering Most New Opportunities
35.2 Congenital Heart Disease (CHD) Market In 2029 - Segments Offering Most New Opportunities
35.3 Congenital Heart Disease (CHD) Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer